Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles

Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation

MEFA (multiepitope fusion antigen)-Novel Technology for Structural Vaccinology, Proof from Computational and Empirical Immunogenicity Characterization of an Enterotoxigenic Escherichia coli (ETEC) Adhesin MEFA

View More »

Google Scholar citation report
Citations : 2051

Journal of Vaccines & Vaccination received 2051 citations as per Google Scholar report

Flyer image
Journal of Vaccines & Vaccination peer review process verified at publons
Flyer image
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
View More
Useful Links
Share This Page
Open Access Journals
View More

Aldar S. Bourinbaiar

Aldar S. Bourinbaiar

Jan Comenius University, Bratislava, Czechoslovakia, Duke university, USA

Biography
Dr. Aldar S. Bourinbaiar is CEO of Immunator, Canada. He received his PhD from Université de la Sorbonne - Université de Paris. Dr. Aldar S. Bourinbaiar has over 20 peer reviewed publications and is funded by the NIH, VA , NSF and several foundations. Dr. Aldar S. Bourinbaiar research interests include vaccines, immunotherapy, infectious diseases, cancer, atherosclerosis